Dawn C. Bir
2019
In 2019, Dawn C. Bir earned a total compensation of $2M as Chief Commercial Officer and Executive Vice President at REATA PHARMACEUTICALS.
Compensation breakdown
| Bonus | $287,550 |
|---|---|
| Option Awards | $1,309,749 |
| Salary | $375,100 |
| Other | $3,500 |
| Total | $1,975,899 |
Bir received $1.3M in option awards, accounting for 66% of the total pay in 2019.
Bir also received $287.6K in bonus, $375.1K in salary and $3.5K in other compensation.
Rankings
In 2019, Dawn C. Bir's compensation ranked 5,987th out of 13,971 executives tracked by ExecPay. In other words, Bir earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,987 out of 13,971 | 57th |
Division Manufacturing | 2,241 out of 5,701 | 61st |
Major group Chemicals And Allied Products | 809 out of 2,200 | 63rd |
Industry group Drugs | 683 out of 1,886 | 64th |
Industry Pharmaceutical Preparations | 504 out of 1,398 | 64th |
Source: SEC filing on April 29, 2020.
Bir's colleagues
We found five more compensation records of executives who worked with Dawn C. Bir at REATA PHARMACEUTICALS in 2019.
2019
Manmeet Soni
REATA PHARMACEUTICALS
Chief Financial Officer
2019
J Huff
REATA PHARMACEUTICALS
Chief Executive Officer
2019
Colin Meyer
REATA PHARMACEUTICALS
Chief Medical Officer
2019
Jason Wilson
REATA PHARMACEUTICALS
Executive Vice President, Operations
2019
Michael Wortley
REATA PHARMACEUTICALS